Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07372040
PHASE2

Add-on Diuretics in Acute Decompensated Heart Failure

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

The aim of this study is to compare the efficacy and safety of empagliflozin, acetazolamide, and metolazone as add-on therapies to loop diuretics in patients with acute decompensated heart failure.

Official title: Clinical Study Comparing Empagliflozin, Acetazolamide, and Metolazone as Add-on Therapies to Loop Diuretics in Acute Decompensated Heart Failure

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2026-02-01

Completion Date

2027-02-01

Last Updated

2026-02-04

Healthy Volunteers

No

Interventions

DRUG

empagliflozin

Empagliflozin may augment the natriuretic and aquaretic actions of loop diuretics in patients with acute decompensated heart failure and it does not typically cause electrolyte disturbances and has been shown to improve outcomes in patients with heart failure

DRUG

Acetazolamide

Acetazolamide can augment the action of loop diuretics in patients with acute decompensated heart failure

DRUG

metolazone

Metolazone can augment the action of loop diuretics in patients with acute decompensated heart failure

Locations (1)

Tanta university

Tanta, Egypt